Bioequivalence of levofloxacin tablets in healthy volunteers
Jiangping Lian
Abstract
Jiangping Lian
Abstract
Objective To evaluate the relative bioavailability and bioequivalence of levofloxacin tablets. Methods 18 male healthy volunteers orally took a single dose of 200mg tablets in randamized self-crossover ways .The plasma concentrations of levofloxacin were determined by RP-HPLC with fluorescent detector. Results The pharmacokinetic parameters of levofloxacin reference and test drug were as follows : t_ max (0.99±0.31) and (1.01±0.57) h;C_ max (1.73±0.50) and (1.68±0.39) μg·mL~ -1 ;t_ 1/2β (6.99±1.00) and (6.71±1.10) h;MRT (9.62±1.58) and (9.44±1.47) h; AUC_ (0→24) (12.46±1.69) and (12.05±1.75) μg·h·mL~ -1 , respectively .There was no statistical difference between the reference and the test levofloxacin tablet in pharmacokinetic parameters(P0.05).The relative bioavailability of levofloxacin tablet was (103.80±6.10)%. Conclusion The reference and the test levofloxacin tablets are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the relative bioavailability and bioequivalence of levofloxacin tablets. Methods 18 male healthy volunteers orally took a single dose of 200mg tablets in randamized self-crossover ways .The plasma concentrations of levofloxacin were determined by RP-HPLC with fluorescent detector. Results The pharmacokinetic parameters of levofloxacin reference and test drug were as follows : t_ max (0.99±0.31) and (1.01±0.57) h;C_ max (1.73±0.50) and (1.68±0.39) μg·mL~ -1 ;t_ 1/2β (6.99±1.00) and (6.71±1.10) h;MRT (9.62±1.58) and (9.44±1.47) h; AUC_ (0→24) (12.46±1.69) and (12.05±1.75) μg·h·mL~ -1 , respectively .There was no statistical difference between the reference and the test levofloxacin tablet in pharmacokinetic parameters(P0.05).The relative bioavailability of levofloxacin tablet was (103.80±6.10)%. Conclusion The reference and the test levofloxacin tablets are bioequivalent.
Key concepts: Bioequivalence, Levofloxacin, Bioavailability, Pharmacokinetics, Pharmacology, Crossover study, High-performance liquid chromatography, Chemistry